BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008-2014. BMC Health Serv Res 2018;18:715. [PMID: 30217156 DOI: 10.1186/s12913-018-3529-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 McKeirnan K, Colorafi K, Sun Z, Daratha K, Potyk D, McCarthy J. Improving Pneumococcal Vaccination Rates among Rural Older Adults through Academic Detailing: Medicine, Nursing and Pharmacy Partnership. Vaccines (Basel) 2021;9:317. [PMID: 33807141 DOI: 10.3390/vaccines9040317] [Reference Citation Analysis]
2 Vadlamudi NK, Patrick DM, Rose C, Sadatsafavi M, Hoang L, Marra F. A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada. Vaccine 2022:S0264-410X(21)01673-X. [PMID: 35012778 DOI: 10.1016/j.vaccine.2021.12.065] [Reference Citation Analysis]
3 Rombauts A, Abelenda-Alonso G, Simonetti AF, Verdejo G, Meije Y, Ortega L, Clemente M, Niubó J, Ruiz Y, Gudiol C, Tebé C, Videla S, Carratalà J. Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial-a trial protocol. Trials 2020;21:727. [PMID: 32819439 DOI: 10.1186/s13063-020-04627-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Schneider JE, Cooper JT. Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department. J Med Econ 2022;:1-46. [PMID: 34994273 DOI: 10.1080/13696998.2022.2026686] [Reference Citation Analysis]
5 Odeyemi YE, Herasevich S, Chalmers SJ, Barreto EF, Frank RD, Gajic OO, Yadav H. Biomarker-Concordant Steroid Use in Critically Ill Patients with Pneumonia. Mayo Clin Proc Innov Qual Outcomes 2020;4:649-56. [PMID: 33367210 DOI: 10.1016/j.mayocpiqo.2020.07.011] [Reference Citation Analysis]
6 Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, Chilson E, Snow V, Farkouh R, Pelton S. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children. Emerg Infect Dis 2021;27:1627-36. [PMID: 34013855 DOI: 10.3201/eid2706.204238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mohiuddin AK. The Excellence of Pharmacy Practice. Innov Pharm 2020;11. [PMID: 34017646 DOI: 10.24926/iip.v11i1.1662] [Reference Citation Analysis]
8 Peck Palmer OMG. Procalcitonin's Adjunct Role in the Diagnosis and Management of Pneumonia. Clin Chem 2019;65:1474-6. [PMID: 31672860 DOI: 10.1373/clinchem.2019.312520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Pickens C, Wunderink RG, Qi C, Mopuru H, Donnelly H, Powell K, Sims MD. A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia. Diagn Microbiol Infect Dis 2020;98:115179. [PMID: 32927409 DOI: 10.1016/j.diagmicrobio.2020.115179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Deb A, Guggisberg P, Mutschler T, Owusu-Edusei K, Bencina G, Johnson KD, Ignacio T, Mathijssen D, Qendri V. Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland. Expert Rev Vaccines 2022. [PMID: 35220875 DOI: 10.1080/14760584.2022.2046468] [Reference Citation Analysis]
11 Rossides M, Kullberg S, Eklund A, Di Giuseppe D, Grunewald J, Askling J, Arkema EV. Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study. Eur Respir J 2020;56:2000767. [PMID: 32366492 DOI: 10.1183/13993003.00767-2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Vakharia RM, Mannino A, Salem HS, Roche MW, Wong CHJ, Mont MA. The association between cannabis use disorder and the outcome following primary total hip arthroplasty : analysis of a nationwide administrative claims database. Bone Joint J 2021;103-B:111-5. [PMID: 34192906 DOI: 10.1302/0301-620X.103B7.BJJ-2020-2424.R1] [Reference Citation Analysis]
13 Owusu-Edusei K, Deb A, Johnson KD. Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA. Infect Dis Ther 2022. [PMID: 35084647 DOI: 10.1007/s40121-022-00588-x] [Reference Citation Analysis]
14 Vadlamudi NK, Sadatsafavi M, Patrick DM, Rose C, Hoang L, Marra F. Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study. Value in Health 2022. [DOI: 10.1016/j.jval.2022.03.017] [Reference Citation Analysis]
15 Yang H, Yue R, Zhou J, Zeng Z, Wang L, Long X, Ding N, Huang X. Study on metabonomics of Chinese herbal medicine in the treatment of type 2 diabetes mellitus complicated with community-acquired pneumonia. Medicine (Baltimore) 2020;99:e22160. [PMID: 32925778 DOI: 10.1097/MD.0000000000022160] [Reference Citation Analysis]
16 Darden DB, Moore FA, Brakenridge SC, Navarro EB, Anton SD, Leeuwenburgh C, Moldawer LL, Mohr AM, Efron PA, Mankowski RT. The Effect of Aging Physiology on Critical Care. Crit Care Clin 2021;37:135-50. [PMID: 33190766 DOI: 10.1016/j.ccc.2020.08.006] [Reference Citation Analysis]
17 Pereira JM, Xu S, Leong JM, Sousa S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front Immunol 2022;13:878244. [DOI: 10.3389/fimmu.2022.878244] [Reference Citation Analysis]
18 Won J, Monroy GL, Huang PC, Hill MC, Novak MA, Porter RG, Spillman DR, Chaney EJ, Barkalifa R, Boppart SA. Assessing the Effect of Middle Ear Effusions on Wideband Acoustic Immittance Using Optical Coherence Tomography. Ear Hear 2020;41:811-24. [PMID: 31634213 DOI: 10.1097/AUD.0000000000000796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
19 Steffens C, Sung M, Bastian LA, Edelman EJ, Brackett A, Gunderson CG. The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis. J Gen Intern Med 2020;35:3315-22. [PMID: 32885375 DOI: 10.1007/s11606-020-06155-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rajamaki B, Hartikainen S, Tolppanen AM. Psychotropic Drug-Associated Pneumonia in Older Adults. Drugs Aging 2020;37:241-61. [PMID: 32107741 DOI: 10.1007/s40266-020-00754-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Hopkins TM, Juang P, Weaver K, Kollef MH, Betthauser KD. Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia. Clin Ther 2019;41:2540-8. [PMID: 31676040 DOI: 10.1016/j.clinthera.2019.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liu K, Lee GC. Healthcare utilisation and cost expenditures for pneumonia in individuals with diabetes mellitus in the USA. Epidemiol Infect 2019;147:e212. [PMID: 31364575 DOI: 10.1017/S0950268819000979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Hu T, Podmore B, Barnett R, Beier D, Galetzka W, Qizilbash N, Haeckl D, Weaver J, Boellinger T, Mihm S, Petigara T. Incidence of acute otitis media in children < 16 years old in Germany during 2014-2019. BMC Pediatr 2022;22:204. [PMID: 35418046 DOI: 10.1186/s12887-022-03270-w] [Reference Citation Analysis]
24 Lourdesamy Anthony AI, Zam Z, Hussin N. A Hospital-based Study on the Local Epidemiology of Pneumonia Including the Contribution of Legionella Pneumonia. Malays J Med Sci 2020;27:79-88. [PMID: 33447136 DOI: 10.21315/mjms2020.27.6.8] [Reference Citation Analysis]
25 Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines 2019;18:327-41. [PMID: 30759352 DOI: 10.1080/14760584.2019.1582337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]